Drug Type Chemical drugs |
Synonyms- |
Target |
Mechanism PLK inhibitors(Polo like kinase inhibitors), Serine/threonine-protein kinase Aurora inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC21H13Cl2N3O2S |
InChIKeyMRITYVDXXFOOAU-UHFFFAOYSA-N |
CAS Registry2247919-28-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colonic Cancer | Discovery | CN | 12 Sep 2019 |